Acarus Siro IgE

If you have persistent congestion, sneezing, asthma, or itchy skin and standard house dust mite testing has not fully explained your symptoms, storage mites may be part of the picture. Acarus siro is one of the most common storage mites, found in flour, grain, hay, and damp household environments, and your immune system can quietly build antibodies against it long before you connect the dots.

This test checks for sIgE (specific immunoglobulin E) antibodies in your blood that recognize Acarus siro proteins. A positive result tells you your immune system has flagged this mite as a threat, which can drive allergic rhinitis, asthma, atopic dermatitis, or occupational respiratory symptoms in people exposed to grain, baking, or farming environments.

What This Antibody Actually Tells You

IgE is the antibody your body makes when it has decided a substance is dangerous, even if that substance is harmless to most people. B cells in your immune system produce IgE that locks onto specific allergen proteins, in this case proteins from Acarus siro. When you encounter the mite again, the IgE triggers mast cells and basophils (immune cells that store histamine) to release histamine and other chemicals, producing the symptoms you recognize as an allergic reaction.

A detectable Acarus siro IgE level signals sensitization, meaning your immune system has been primed. Sensitization is not the same as a clinical allergy. Some people with a positive result have clear symptoms when exposed to flour, grain dust, or damp bedding. Others have a positive antibody result without obvious symptoms. The number is one piece of evidence, not the whole diagnosis.

How Common Sensitization Is

Prevalence varies dramatically depending on who is tested. In a general population study of 600 people in southwestern Ohio, 2.3% had detectable serum IgE to Acarus siro, and 5.3% reacted to at least one storage mite. The picture changes sharply in people already known to have allergies.

Among allergic rhinitis patients in Central China who already tested positive to house dust mite, 81.5% were also positive for Acarus siro IgE. Most of these readings landed in the lower-to-middle range (class 2 to 3), lower than typical house dust mite levels in the same group. In Northern Europe, a study of 1,180 adults found that storage mite sensitization was as common as house dust mite sensitization and was independently linked to respiratory symptoms and asthma. There is some regional variation, however: a separate Finnish study found mite sensitization had little independent association with asthma in that population, so the clinical weight of a positive result depends partly on where you live and how you are exposed.

Allergic Rhinitis and Asthma

Mite-specific IgE is one of the strongest signals for allergic rhinitis and asthma. Across multiple studies of house dust and storage mites, people with higher allergen-specific IgE and broader sensitization across many mite components tend to have more severe symptoms, more polysensitization, and a higher risk of moving from rhinitis alone to rhinitis plus asthma.

A study of 500 allergic patients found that polysensitization (reacting to many allergens at once) was present in 81% and was linked to more severe rhinitis and asthma. In allergic asthmatic children sensitized to house dust mites, total and allergen-specific IgE levels tracked with blood eosinophilia (a type of allergy-related white blood cell) and exhaled nitric oxide, two markers of active allergic inflammation in the airways.

Atopic Dermatitis

Mite sensitization is not just a respiratory problem. In a study of 384 patients, sensitization to specific house dust mite molecules (Der p 5, 20, and 21) was linked to severe atopic dermatitis. That study did not isolate Acarus siro specifically, so this is indirect evidence, but it fits a broader pattern: high or multi-component mite IgE often associates with worse skin disease in people with atopic conditions.

Occupational Exposure

Storage mites thrive where grain and flour are stored. In a study of 3,018 farmers on Gotland, 6.2% of the whole farming population had storage mite allergy, climbing to 37.8% among those with potential IgE-mediated respiratory symptoms. In Danish grain elevator workers, 15.9% were sensitized to storage mites and 6.4% had respiratory storage mite allergy. UK bakery workers also showed occupational exposure-related sensitization to storage mites including Acarus siro.

If you work with grain, flour, animal feed, or in agriculture, and you have new or worsening respiratory symptoms, this is one of the most actionable groups for testing. The mite is doing real biological work in your airways, and identifying the trigger opens the door to exposure control and targeted treatment.

Cross-Reactivity with House Dust Mites

Acarus siro shares some protein structures with house dust mites, so a positive result can sometimes reflect cross-reactivity rather than direct storage mite sensitization. In one urban population study, every person with storage mite IgE also had house dust mite IgE, and inhibition experiments showed considerable cross-reactivity between Dermatophagoides pteronyssinus and Acarus siro. A Korean study went further, suggesting that in non-occupational dust mite allergic patients, IgE reactivity to Acarus siro may be almost entirely attributable to cross-reactivity with Dermatophagoides farinae rather than genuine storage mite sensitization. In contrast, the Ohio general population study found that the binding patterns suggested limited cross-reactivity and largely independent sensitization to different storage mites.

The takeaway is that interpretation depends on your full mite IgE picture. If you are strongly sensitized to house dust mite and have a weak Acarus siro signal, cross-reactivity is a reasonable explanation. If you have a strong Acarus siro signal, occupational or environmental exposure, and symptoms that fit, the storage mite is more likely the genuine driver.

Why a Single Reading Is Not Enough

Specific IgE is not a static number. It rises and falls with ongoing allergen exposure, season, treatment, and overall immune state. Classic descriptions of allergen immunotherapy show that mite-specific IgE often rises early in treatment before falling over months to years, though modern component-level studies do not always reproduce this pattern, and some patients show little change at 18 months while only clinical responders see clear IgE decreases. Either way, a single value cannot tell you whether your sensitization is stable, increasing, or responding to intervention.

Get a baseline reading now, then retest in 6 to 12 months if you are making meaningful changes (avoiding grain dust, starting immunotherapy, treating concurrent atopic disease). If your symptoms shift or new exposures begin (a new job, a move into a damp home), retest to see whether sensitization is climbing. At least annual tracking is a reasonable editorial suggestion, not a guideline-based standard, for anyone with persistent allergic disease.

When Results Can Be Misleading

• Recent biologic therapy: dupilumab (an IL-4 and IL-13 blocker used for severe atopic dermatitis) substantially lowers total and mite-specific IgE over 52 weeks, which can mask underlying sensitization on a single test.
• Active allergen immunotherapy: IgE often rises in the first months of treatment before falling, although this classic biphasic pattern is not seen in every patient or every modern study, so a reading taken during treatment can be hard to interpret without a baseline.
• Cross-reactivity with house dust mite: in non-occupational settings, a positive Acarus siro result may reflect immune recognition of a shared protein rather than independent storage mite sensitization. In some populations (such as Korean dust mite allergic patients), Acarus siro IgE appears to be almost entirely cross-reactive with Dermatophagoides farinae.
• Total IgE context: very high total IgE from other causes (parasitic infection, severe atopy) can shift how a specific IgE value should be interpreted, so total IgE is often measured alongside.

What to Do With an Out-of-Pattern Result

A positive Acarus siro IgE is most actionable when it matches your symptoms and exposures. If your result is positive and you have respiratory or skin symptoms, consider testing the full mite panel (house dust mite Dermatophagoides pteronyssinus and farinae, Blomia tropicalis, and other storage mites like Lepidoglyphus destructor and Tyrophagus putrescentiae). This helps separate cross-reactivity from independent sensitization.

Pair the result with total IgE and a broader allergy workup if symptoms are unclear. An allergist or immunologist can run component-resolved diagnostics, skin prick testing, or component-specific assays to pinpoint which proteins are driving your response. If you have occupational exposure and a positive result, an occupational medicine or pulmonology referral is reasonable. For severe rhinitis or asthma combined with strong mite sensitization, allergen immunotherapy is the main disease-modifying option.